PPFIA1 and chronic myelogenous leukemia, BCR-ABL1 positive: The approach used in this study both enabled us to gain biological insight into the role of PPFIA1 in CML and laid the foundation for a future siRNA-based therapeutic approach targeting PPFIA1 in a subpopulation of leukemia cells.